Biggest News Aggregation in the World
📰 Michael Erman News

Page 28 - Michael Erman News Today

Fast, Ad-Free News Updates

Stay updated with breaking news from Michael Erman. Real-time updates on events, politics, business and more.

Merck posts narrower-than-expected loss as sales of top drugs beat Street estimates

(Reuters) -Merck & Co posted better-than-expected second-quarter sales on Tuesday on strong demand for its two top-selling products, cancer immunotherapy Keytruda and human papillomavirus (HPV) vaccine Gardasil. Shares of Merck rose about 2% at $108.45 in premarket trading after the company also raised its full-year revenue forecast. Merck said Keytruda sales for the quarter jumped 19% to $6.3 billion, surpassing analysts' average estimate of $5.9 billion.
United States Rob Davis Merck Co Wall Street Michael Erman Bill Berkrot
Source: yahoo.com

Drugmakers go under the skin, skirting early US Medicare price negotiations

Injectable versions of some widely-used cancer drugs including Johnson & Johnson's blockbuster multiple myeloma treatment Darzalex are likely to be excluded from new U.S. government price negotiations for years, drugmakers told Reuters, protecting billions in revenue. J&J, Merck & Co, which is testing an injectable version of its top-selling immunotherapy Keytruda, and Halozyme Therapeutics, which licenses the critical new ingredient, hyaluronidase, for subcutaneous drugs, a...
United States Joseph Wolk Caroline Humer Helen Torley Patrick Wingrove Michael Difiore
Source: yahoo.com

Stay Updated with Latest News

Get breaking news updates delivered to your inbox

Browse All News →

Explore More Categories

World News India News Business Technology Sports Entertainment Health Science